1858 Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.16M Buy
1,515
+118
+8% +$87.8K 0.81% 37
2025
Q2
$1.09M Buy
1,397
+119
+9% +$92.5K 0.8% 35
2025
Q1
$1.06M Buy
1,278
+245
+24% +$204K 0.89% 32
2024
Q4
$797K Buy
1,033
+775
+300% +$642K 0.63% 49
2024
Q3
$229K Sell
258
-66
-20% -$59.3K 0.19% 107
2024
Q2
$293K Buy
+324
New +$259K 0.24% 79

Other funds holding LLY

1858 Wealth Management's LLY Position: Q3 2025 in Review

1858 Wealth Management increased its Eli Lilly (LLY) stake by 8.4% in Q3 2025, buying an estimated $87.8K and bringing the position to 1,515 shares worth $1.16M. The position accounts for 0.81% of the portfolio, ranked #37.

1858 Wealth Management first reported a position in LLY in Q2 2024 and has held it in 6 quarters since. 3,898 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • 1858 Wealth Management held 1,515 shares of Eli Lilly worth $1.16M as of Q3 2025.
  • 1858 Wealth Management bought 118 Eli Lilly shares in Q3 2025, an estimated $87.8K.
  • Eli Lilly made up 0.81% of 1858 Wealth Management's portfolio in Q3 2025, its #37 holding.
  • 1858 Wealth Management first reported a position in Eli Lilly in Q2 2024 and has held it in 6 quarters since.
  • 3,898 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on 1858 Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.